Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$81.33
+0.69%
Mkt Cap $4.88B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (15 analysts)
$81.90
Range $49.00 – $106.00
Implied Upside
+0.7%
Consensus $81.90 vs current $81.33
NASDAQ·Healthcare·Biotechnology
$81.33
+0.69%
Mkt Cap $4.88B
Buy
17
Hold
0
Sell
0
Price Target (15 analysts)
$81.90
Range $49.00 – $106.00
+0.7%
Consensus $81.90 vs current $81.33